164 related articles for article (PubMed ID: 11728256)
21. Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme.
Hirota T; Ohki K; Kawagishi R; Kajimoto Y; Mizuno S; Nakamura Y; Kitakaze M
Hypertens Res; 2007 Jun; 30(6):489-96. PubMed ID: 17664851
[TBL] [Abstract][Full Text] [Related]
22. [Structural and functional changes of the microcirculation in hypertension: influence of pharmacological therapy].
Agabiti-Rosei E
Drugs; 2003; 63 Spec No 1():19-29. PubMed ID: 12708883
[TBL] [Abstract][Full Text] [Related]
23. Remodelling of conduit arteries in hypertension: special emphasis on the mechanical and metabolic consequences of vascular hypertrophy.
Hayoz D; Brunner HR
Blood Press Suppl; 1997; 2():39-42. PubMed ID: 9495625
[TBL] [Abstract][Full Text] [Related]
24. A model of coronary artery endothelial dysfunction in the sleeping lamb.
Hamilton GS; Edwards B; Solin P; Walker AM
Sleep Med; 2006 Oct; 7(7):573-9. PubMed ID: 16996308
[TBL] [Abstract][Full Text] [Related]
25. Evidence for benefits of perindopril in hypertension and its complications.
Laurent S
Am J Hypertens; 2005 Sep; 18(9 Pt 2):155S-162S. PubMed ID: 16125052
[TBL] [Abstract][Full Text] [Related]
26. Blockade of endothelial enzymes: new therapeutic targets.
López-Jaramillo P; Casas JP
J Hum Hypertens; 2002 Mar; 16 Suppl 1():S100-3. PubMed ID: 11986905
[TBL] [Abstract][Full Text] [Related]
27. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment.
Schiffrin EL
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1192-200. PubMed ID: 15607629
[TBL] [Abstract][Full Text] [Related]
28. Vascular remodeling: the role of angiotensin-converting enzyme inhibitors.
Chrysant SG
Am Heart J; 1998 Feb; 135(2 Pt 2):S21-30. PubMed ID: 9488609
[TBL] [Abstract][Full Text] [Related]
29. Functional and structural vascular remodeling in elite rowers assessed by cardiovascular magnetic resonance.
Petersen SE; Wiesmann F; Hudsmith LE; Robson MD; Francis JM; Selvanayagam JB; Neubauer S; Channon KM
J Am Coll Cardiol; 2006 Aug; 48(4):790-7. PubMed ID: 16904551
[TBL] [Abstract][Full Text] [Related]
30. Pulse wave analysis to assess vascular compliance changes in stable renal transplant recipients.
Cohen DL; Warburton KM; Warren G; Bloom RD; Townsend RR
Am J Hypertens; 2004 Mar; 17(3):209-12. PubMed ID: 15001192
[TBL] [Abstract][Full Text] [Related]
31. Targeting endothelial dysfunction in hypertensive subjects.
Thuillez C; Richard V
J Hum Hypertens; 2005 Jun; 19 Suppl 1():S21-5. PubMed ID: 16075029
[TBL] [Abstract][Full Text] [Related]
32. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
Cersosimo E; DeFronzo RA
Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
[TBL] [Abstract][Full Text] [Related]
33. Large and small artery endothelial function in patients with essential hypertension--effect of ACE inhibition and beta-blockade.
Buus NH; Jørgensen CG; Mulvany MJ; Sørensen KE
Blood Press; 2007; 16(2):106-13. PubMed ID: 17612909
[TBL] [Abstract][Full Text] [Related]
34. [Pulse pressure in the therapeutic management of hypertension?].
Scholze J
Herz; 2004 May; 29(3):276-89. PubMed ID: 15167954
[TBL] [Abstract][Full Text] [Related]
35. Increased vascular compliance/decreased cardiovascular risk: what the studies tell us.
Frishman WH
Heart Dis; 2000; 2(5):384-8. PubMed ID: 11728287
[TBL] [Abstract][Full Text] [Related]
36. Endothelial dysfunction: its pathogenic role in atherosclerosis and its reversal by ACE inhibition.
Neutel JM
Postgrad Med; 2000 Oct; 108(5 Suppl):4-11. PubMed ID: 19667535
[TBL] [Abstract][Full Text] [Related]
37. Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis: aging and arterial compliance.
McVeigh GE; Bratteli CW; Morgan DJ; Alinder CM; Glasser SP; Finkelstein SM; Cohn JN
Hypertension; 1999 Jun; 33(6):1392-8. PubMed ID: 10373222
[TBL] [Abstract][Full Text] [Related]
38. [Vasomotor activity and vascular geometry].
Escourrou P
Arch Mal Coeur Vaiss; 1991 Jan; 84 Spec No 1():53-7. PubMed ID: 2053833
[TBL] [Abstract][Full Text] [Related]
39. Maintenance of vascular integrity: role of nitric oxide and other bradykinin mediators.
Cosentino F; Lüscher TF
Eur Heart J; 1995 Nov; 16 Suppl K():4-12. PubMed ID: 8869130
[TBL] [Abstract][Full Text] [Related]
40. Converting enzyme inhibitors and their effects on the renin-angiotensin system of the blood vessel wall.
Unger T; Gohlke P; Ganten D; Lang RE
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S8-16. PubMed ID: 2474111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
